Yes. Controlling high blood pressure can lower dementia risk, although researchers have not identified one prevention target that suits everyone. The strongest recent evidence comes from adults with uncontrolled hypertension, meaning persistently high blood pressure. Other trials show clearer protection against mild cognitive impairment than against dementia itself.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What did the latest trial find?
- What has other research shown?
- How convincing is the overall evidence?
- What should readers do now?
What did the latest trial find?
A 2025 trial followed 33,995 rural Chinese adults aged 40 or older for 48 months. Intensive blood-pressure treatment reduced all-cause dementia risk by 15% compared with usual care, according to the Nature Medicine trial. Community providers started and adjusted medicines toward a target below 130/80 mm Hg.
The program produced average net reductions of 22.0 mm Hg systolic and 9.3 mm Hg diastolic compared with usual care. This was an open-label, provider-led program in rural China. Its results support blood-pressure control for brain health, but they do not establish one ideal target or care model for every person.
What has other research shown?
SPRINT MIND included 9,361 adults aged 50 or older in the United States and Puerto Rico. Participants had hypertension but did not have diabetes or a previous stroke. Targeting systolic pressure below 120 rather than below 140 significantly reduced mild cognitive impairment, or MCI.
MCI describes measurable problems with memory or thinking that are greater than expected but do not necessarily amount to dementia. The intensive group had 14.6 MCI cases per 1,000 person-years, compared with 18.3 under standard treatment, according to the JAMA report. Extended follow-up still did not produce a statistically conclusive dementia-only result. The combined outcome of MCI or dementia remained lower, but researchers obtained cognitive data from only 4,232 of 7,221 people eligible for recontact and recorded fewer dementia cases than planned, as detailed in the 2025 Neurology analysis.
How convincing is the overall evidence?
The evidence now points in the same general direction across several randomized studies. Blood-pressure treatment appears capable of reducing cognitive decline and may prevent some dementia cases. A 2022 analysis pooled individual data from five double-blind randomized trials.
Antihypertensive treatment was associated with 13% lower odds of developing dementia, alongside an average blood-pressure reduction of 10/4 mm Hg. The uncertainty concerns the size and reach of the benefit, not whether hypertension deserves treatment. Studies used different targets, populations, follow-up periods, and care systems. Some trials also lacked enough dementia cases to produce a definite dementia-only result.
What should readers do now?
Blood-pressure control already has established cardiovascular benefits, with possible brain protection providing another reason to take it seriously. Intensive treatment should still be individualized rather than chosen solely to prevent dementia.
Practical next steps include: The American Heart Association's guidance supports regular measurement plus clinician-guided lifestyle changes and medication when needed. Do not select an intensive target or alter medication on your own solely because of dementia concerns.
- Have blood pressure measured regularly.
- Discuss repeated high readings with a clinician.
- Ask what target fits your health circumstances.
- Follow clinician-guided lifestyle changes.
- Take prescribed medication as directed and discuss adjustments before changing treatment.
